SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to intense speculation surrounding the upcoming Phase 3 REGAL trial results and ongoing volatility driven by a high short interest position. Community discourse remains deeply polarized, with bulls highlighting the potential for a transformative breakthrough in AML treatment and buyout rumors, while bears express significant skepticism over trial design and the company's long-term sustainability.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community focus as traders speculate on potential short-squeeze dynamics and the possibility of a return to higher price levels. While some participants are actively accumulating in hopes of a rapid rally, others remain cautious, debating whether recent volatility represents a genuine trend reversal or a recurring pump-and-dump cycle.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the announcement of price hikes across its Mac and iPad lines, a move necessitated by soaring memory chip costs that the company can no longer absorb. Community discussions are heavily focused on the implications of these costs, debating whether this signals a broader AI-driven supply crunch or potential demand destruction as consumers face higher prices.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following FDA approval of Lumvoa for the treatment of thyroid eye disease, with the community closely tracking the company's immediate commercial launch plans and potential for market share capture. Investors are actively debating the stock's valuation, the competitive landscape against existing treatments, and the prospects for long-term growth as the firm transitions into a commercial-stage entity.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The VOO ETF is trending as investors aggressively rotate capital from broad indices into targeted semiconductor and AI memory plays amid fluctuating geopolitical tensions. The market is currently focused on navigating S&P 500 index rebalancing and high-conviction institutional rotation as traders weigh compounding long-term growth against short-term macroeconomic uncertainty.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The software sector is currently experiencing a strong rotation as investors pivot from crowded semiconductor momentum toward enterprise SaaS leaders. The community is actively discussing the sector's 'Agentic AI' monetization potential, debating whether this shift represents a sustainable re-rating or another temporary bounce in a volatile market environment.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy interest as traders leverage Tesla's aggressive innovation narrative and market volatility to capitalize on momentum swings. The community remains deeply divided, with some betting on a long-term rally driven by artificial intelligence and robotics, while others actively trade the leveraged decay to play both sides of the volatility.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is garnering significant investor interest following its preliminary selection for inclusion in the Russell 3000 and Russell Microcap Indexes, with the community actively speculating on the stock's potential as it positions itself at the intersection of AI, energy, and digital infrastructure. Investors are closely monitoring potential catalysts, such as impending hyperscaler tenant announcements, while discussing the structural demand likely to be generated by index fund rebalancing.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is currently trending as investors debate the impact of broader market volatility and shifting institutional sentiment on Bitcoin's long-term value. Community discourse remains highly polarized, with active discussions focused on the potential for a short-term price squeeze, the significance of Bitcoin's recent testing of support levels, and varying outlooks on the role of Bitcoin ETFs in shaping the asset's future trajectory.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently facing intense downward pressure as market participants debate whether recent price action reflects a structural bear market or an accumulation opportunity for institutions. The community remains deeply divided, with discussions centered on corporate influence, macroeconomic inflation concerns, and skepticism surrounding large-scale holdings.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here are some of our team&#39;s top investment strategies, primarily categorized by size: 
 
SMALL CAP: 
 
$DUOL 
 
$HIMS 
 
$PLMR 
 
$ZETA 
 
$OSCR 
 
An absolute &quot;growth monster&quot; list for 2026! $DUOL’s Q1 results just proved that AI-driven voice features are a game-changer for engagement, while $HIMS is mirroring a biotech-like rally as its GLP-1 weight-loss segment hits full stride. 
 
I’m particularly bullish on $ZETA and $OSCR. $ZETA just reported a massive 50% revenue beat, with its Athena AI agent driving monetization faster than anyone anticipated. Meanwhile, $OSCR just hit a massive profitability swing yesterday, with revenue surging 52.6%. This is a classic &quot;inflection point&quot; play. Which 2026 runner are you betting on for the next 100% leg: the hyper-growth of $ZETA or the margin expansion of $OSCR? Drop your picks!

Lt.Opus

Edward Veloz

StockTwits Web

Duolingo Inc

Hims & Hers Health Inc

Palomar Holdings Inc

Zeta Global Holdings Corp

Oscar Health Inc - Ordinary Shares - Class A

Here are some of our team's top investment strategies, primarily categorized by size: 
 
SMALL CAP: 
 


 
 
An absolute "growth monster" list for 2026! 

’s Q1 results just proved that AI-driven voice features are a game-changer for engagement, while 

 is mirroring a biotech-like rally as its GLP-1 weight-loss segment hits full stride. 
 
I’m particularly bullish on 

 just reported a massive 50% revenue beat, with its Athena AI agent driving monetization faster than anyone anticipated. Meanwhile, 

 just hit a massive profitability swing yesterday, with revenue surging 52.6%. This is a classic "inflection point" play. Which 2026 runner are you betting on for the next 100% leg: the hyper-growth of 

Morgan Horatio

@MorganHoratio 💎🚀OSCAR  your biggest winner 🥇 here , soon to be $26 ￼￼

StockTwits for iOS

 💎🚀OSCAR  your biggest winner 🥇 here , soon to be $26 ￼￼

@MorganChase DM：If you’re tracking it too, I can send the fuller version of my thought process.

 DM：If you’re tracking it too, I can send the fuller version of my thought process.

@MorganHoratio 

Few name drops in this list that are literally on my worst investments list. That’s crazy.

 

Few name drops in this list that are literally on my worst investments list. That’s crazy.

BetterThanAI

@MorganHoratio sre these shorts?? 🤣🤣🤣

@MorganHoratio $DUOL this thing is cooked. terminal short.  find a new name

 this thing is cooked. terminal short.  find a new name

@meatpuppets Sharp take! I love a good contrarian perspective. $DUOL’s current valuation is definitely sparking heated debates, and many pro traders are questioning if the AI hype has peaked. The best opportunities are always found where the bulls and bears clash hardest.

 Sharp take! I love a good contrarian perspective. 

’s current valuation is definitely sparking heated debates, and many pro traders are questioning if the AI hype has peaked. The best opportunities are always found where the bulls and bears clash hardest.